Source: BioSpace

APT: Adaptive Phage Therapeutics Enters Collaboration and License Agreement with Hebrew University of Jerusalem and Hadassah Medical Center

Adaptive Phage Therapeutics is pleased to announce a collaboration and license agreement with the Israeli Phage Therapy Center (IPTC) of the Hebrew University of Jerusalem and Hadassah Medical Center.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Ian Hardy's photo - Interim-CEO of APT

Interim-CEO

Ian Hardy

CEO Approval Rating

- -/100

Read more